Peptides and niacinamide can occur together in the same serum, cream, or more complex cosmetic formula. Studies involving humans have also been published that evaluated products containing both groups of ingredients. However, the presence of two separately tested categories of ingredients in one formula does not automatically mean that their combination will work better than each of them used separately. Whether a particular combination provides an additional effect depends on the exact composition of the formulation used in the comparative product study, the population studied, the duration of observation, and the specific parameter being evaluated.
This distinction is particularly important because in skin care communications, very different biological and cosmetic effects are often combined under general terms such as „improvement of skin condition” or „support of the skin barrier.” Hydration, transcutaneous water loss, redness, pigmentation, elasticity, and the appearance of wrinkles are not the same endpoints. A formulation may cause a measurable change in one of these parameters without simultaneously improving the others.
Similarly, if the serum contains niacinamide, several peptides, moisturizing ingredients, and other active substances, the improvements observed when using the entire product cannot be automatically attributed to any single designated ingredient.
Therefore, from a scientific point of view, the more useful question is not simply: „Can peptides be combined with niacinamide?” Published studies already show that they can coexist in ready-made cosmetic formulations. What is significantly more important is determining exactly what was demonstrated for a specific formulation, how the effect was measured, with what product it was compared, whether the proportion of individual ingredients could be isolated, and what uncertainties still remain.
This approach makes it easier to separate the actual data regarding formulations from the much broader marketing claims.
The role of peptides and niacinamide
Niacinamide is a form of vitamin B3, not a peptide
Niacinamide, also known as nicotinamide, is a form of vitamin B3. Chemically speaking, it is a relatively small molecule and is not composed of amino acids linked by peptide bonds. Therefore, it is fundamentally a different substance than a peptide, even though both types of ingredients are present in the same cosmetic product.
Niacinamide has been studied with regard to various aspects of epidermal biology and visible skin characteristics. However, data regarding skin barrier function, pigmentation, hydration, or appearance should be interpreted according to the specific parameter being evaluated in a given study, rather than combining all the results into a single general statement that niacinamide „improves the skin.”.
Experimental studies analyzed, among other things, the effect of niacinamide on the production of epidermal lipids. In one study combining experiments on keratinocytes with observations after topical application, changes associated with the synthesis of ceramides and other lipids, as well as with water loss by dry skin, were described.[1]
These results provide a useful biological context that helps to understand why niacinamide is included in formulations promoted as supporting the skin barrier. However, they do not mean that every product containing niacinamide will have the same effect.
The component's effect on specific biological pathways also does not tell us what will happen after placing any concentration of this component in any cosmetic base. The finished formulation determines the environment in which niacinamide is delivered, maintained, and ultimately tested.
The biological rationale derived from the properties of a single component and the actual action of the finished product should therefore be treated as related but distinct levels of evidence.
Peptides constitute a very diverse group of compounds
The term „peptide” describes molecules containing amino acid residues linked by peptide bonds. However, in cosmetics, this definition encompasses a very diverse group of substances.
The cosmetic product may contain one precisely defined peptide, a chemically modified peptide, a peptide linked to a lipid fragment, several different peptides, or a mixture of peptide fragments formed from a larger protein. These substances can significantly differ in particle size, chemical properties, stability, formulation retention, and biological activity.
They should therefore not be treated as mutually interchangeable just because each of them can be described as a peptide.
Some studies on cosmetic peptides focus on signaling related to extracellular matrix and the appearance of wrinkles. Other peptides are analyzed for completely different biological activities. The mere appearance of the word „peptide” on the list of ingredients does not therefore determine the mechanism of action, does not prove that the molecule reaches the living layers of the skin, does not confirm its stability in the formulation, nor does it demonstrate a clinically visible effect.
A controlled study using palmitylated pentapeptide clearly demonstrates why accurate identification of the ingredient is important. Researchers compared a moisturizing preparation containing this peptide with an appropriately matched control preparation in 93 women for 12 weeks and described an improvement in parameters related to fine lines and wrinkles.[2]
This is important evidence regarding a specific preparation containing a specific peptide.
However, this does not mean that all cosmetic peptides provide the same result. More importantly, in the context of this article, the study does not show that adding niacinamide to this peptide would increase its effectiveness.
Therefore, the claims should remain related to a specific peptide, a specific formulation, and the actually intended effect.
Complementary assumptions do not imply proven synergistic effects
A cosmetic formulation can be rationally designed in such a way that the individual ingredients affect different skin properties.
Niacinamide can be used, among other things, due to studies on epidermal lipids or processes related to pigmentation, while a specific peptide can be used due to data regarding wrinkle appearance. The humectants and emollients present in the same formula can independently affect skin hydration and surface properties.
Such a method of designing a cosmetic product can be scientifically justified.
However, complementary justifications are not the same as proven complementary effects.
Three levels of claims should be distinguished. The first is co-occurrence, which means that both components are present in a single ready-made formulation. The second is an additional benefit, which means that adding one component improves a specific outcome compared to the corresponding base preparation. The third level is synergy, which means that the effect of the combination exceeds the previously defined expectation resulting from the action of the individual components. Proving such an interaction requires a properly designed study and statistical analysis.
The product can work well, even though no synergy has ever been shown for it.
The problem arises when a study showing improvement after the use of a multi-component product is presented as evidence that niacinamide and peptides mutually enhance their biological activity.
These are two different conclusions.
Pigmentation and the function of the skin barrier are different issues
Niacinamide has also been studied in the context of pigmentation.
Laboratory studies combined with clinical observations provided data consistent with a reduction in the transfer of melanocytes between cells.[3] This result should be presented according to the actual scope of the study, rather than being simplified to state that niacinamide blocks all stages of melanin production.
This example also shows why biological mechanisms and cosmetic endpoints should be clearly separated.
The effect associated with pigmentation does not indicate a reduction in transcutaneous loss of water. Similarly, data regarding epidermal lipids or parameters related to the skin barrier do not automatically mean an improvement in pigmentation.
A multi-ingredient formulation containing niacinamide and peptides can be designed to address several skin conditions at the same time, however, any claimed effect still requires proper measurement.
How are formulations combining niacinamide and peptides evaluated?
The starting point is the actual formulation and the appropriate comparative product
Ready-made cosmetic serums contain much more than the ingredients displayed on the front of the packaging.
Humectants, emollients, solvents, lipid-forming agents, preservatives, thickeners, and many other components can affect the hydration, consistency, delivery of ingredients, and overall performance of the product. The base formulation itself, often referred to as the vehicle or base, can also cause measurable changes in the skin.
Therefore, the type of comparative product used is one of the most important elements of the interpretation of a cosmetic study.
If researchers compare a complete product containing niacinamide and peptides with the absence of any product, they can assess whether the use of the entire formulation results in a difference compared to the absence of intervention. However, such a project does not allow determining which component is responsible for the observed change.
Comparing it with the same formulation base, but without the highlighted active ingredient, provides much more useful information if the question concerns the contribution of a specific ingredient.
Similarly, combining two possibly identical formulations that differ only in the presence or absence of a specific peptide provides significantly stronger data about that peptide than comparing two completely different commercial products.
Claims regarding synergy require a more precise design. The most informative would be a separate study of the relevant components and their combination under conditions that allow for comparing individual and combined effects.
The improvement itself before and after the application of the mixture does not constitute evidence of synergy.
Direct pilot study provides significant but limited signal
In a randomized pilot study published in 2024, serum containing niacinamide, postbiotics, and peptides was evaluated in 25 healthy participants. After four weeks, differences in hydration measurements were observed between the intervention and control groups. Redness also decreased compared to the baseline values in the product-using group. At the same time, the results presented in the publication regarding TEWL did not show a significant difference between the groups for this parameter.[4]
This study is particularly important because the formulation containing both niacinamide and peptide components was directly analyzed.
However, the results must remain attributed to the individual endpoints.
A statistically significant change compared to the initial value in one group is not the same as a statistically significant difference between the studied and control groups. These two types of comparisons should not be presented as equivalent.
The study was also small and relatively short. Observing 25 healthy participants for four weeks may provide useful exploratory data, but it does not allow for determining universal efficacy or reliably characterizing rare or delayed reactions.
An additional limitation is the presence of several components, including postbiotics. Therefore, the study does not allow one to independently determine whether the observed change in hydration resulted from the action of niacinamide, peptide components, or the interaction between them.
The most substantiated claim is narrower: a specific multi-component serum containing niacinamide and peptides caused selected measurable changes during a small randomized pilot study.
Studies of entire care regimens evaluate the entire regimen
The interpretation becomes even more difficult when researchers evaluate the entire care regimen instead of a single serum.
In one randomized study involving 196 women, the cosmetic regimen containing niacinamide, peptides, and retinyl propionate was compared with a regimen based on tretinoin. In the first eight weeks in the group using the cosmetics, favorable results were observed regarding wrinkles and tolerability, and smaller groups were observed for a longer period of time.[5]
This constitutes an important study involving humans regarding the entire evaluated cosmetic regimen.
However, it does not allow for the identification of interactions between niacinamide itself and peptides.
The regimens differed in many respects, including the moisturizing preparations used, the retinoid ingredients, and the remaining elements of the skincare regimen. Therefore, each difference between the groups refers to the complete interventions rather than solely to the two highlighted ingredients.
The chemical identity of the retinoid is also important. The propionate form of retinyl, retinol and tretinoin are different compounds and should not be treated as synonyms.
More information about why the presence of peptides and retinoid in a single routine is not automatically evidence of additional benefit or the compatibility of all formulations can be found in a separate article: Peptides and retinol.
The study therefore supports conclusions regarding a specific cosmetic regimen. It does not prove that any serum containing niacinamide and peptides is equivalent to prescription therapy, nor that only niacinamide and peptides are responsible for the observed effects.
The registration of the study, randomization, and blinding improve the ability to interpret the results.
Some elements of the research project facilitate the proper interpretation of clinical data.
The registration of the study can document previously planned results and methods, which makes it easier to assess whether the later published results correspond to the original plan.
Randomization helps to reduce systematic differences between groups from the very beginning of the study.
The masking can limit the influence of expectations on the subjective assessments of participants or researchers.
However, none of these methodological characteristics makes the result automatically valid for all cosmetic formulations and all populations.
During the evaluation of the study, it is also worth checking how many participants were included, how many completed the study, how many were included in the final analysis, why some participants dropped out, how long the observation lasted, what comparator product was used, and how adverse events were reported.
If multiple endpoints are being evaluated, results that are unchanged or unfavorable should be presented as clearly as the favorable results.
Statistical significance also requires context. A low statistical probability value by itself does not inform us about how large the effect was, whether it was visible, whether the participants considered it significant, or whether it persisted after the product was discontinued.
Statistical significance, the magnitude of the effect, its visibility and durability are separate issues.
Skin barrier and appearance parameters
Moisture describes properties related to water.
Corneometry and related techniques estimate the level of hydration by measuring electrical properties associated with the outer layers of the skin.
These measurements can provide useful quantitative data, but they must be described precisely. The corneometric result is not a direct measure of collagen production, skin regeneration, or its overall „health”.
The base of the cosmetic product itself can affect hydration.
Humectants, occlusive agents, and emollients can increase water-related parameters regardless of the presence of the designated peptide. Therefore, if a multi-component serum increases hydration, this is a valuable scientific result, but it does not automatically prove that the peptide is responsible for it.
The moment of measurement is also important.
A reading obtained shortly after applying the product may partially reflect the direct effect of the formulation. A measurement performed after a standardized period without applying the product may answer a slightly different question.
Therefore, before comparing the results regarding moisture between different products, the test protocol must be taken into account.
TEWL measures another property of the skin
Transcutaneous water loss, or TEWL, describes the amount of water that passes through the skin into the surrounding environment.
This parameter is widely used in studies of the barrier function of the skin, but the experimental conditions influence the results of the TEWL. Environmental humidity, temperature, acclimatization time, and the method of measurement can all affect the result, which is why standardization and an appropriate comparative product are important.
In a study of formulations containing niacinamide administered to 20 healthy volunteers for 28 days, forearm skin was evaluated. The researchers analyzed TEWL along with the properties of the stratum corneum, including parameters related to corneocytes and the activity of selected enzymes. [6]
This shows why skin barrier testing may involve several complementary measurements instead of a single value.
Moisture and TEWL are related to the skin's water economy, but they do not measure the same property.
The product can improve hydration while simultaneously causing a slight or imperceptible change in TEWL. It is also possible to improve both parameters or to see different directions of change depending on the formulation and the test conditions.
Therefore, increased hydration should not be automatically considered as „repairing the skin barrier”.
The claim regarding the support of the barrier should indicate the actually evaluated parameters related to its functioning.
Redness, pigmentation, wrinkles and elasticity are not the same thing
Redness can be evaluated visually, photographically, or using instrumental methods; however, its reduction does not in itself allow the cause of the original redness to be determined.
The cosmetic endpoint regarding redness therefore does not constitute proof of diagnosis or treatment for rosacea, eczema, or any other dermatological disease.
The measurements of pigmentation refer to a completely different property.
Similarly, the appearance of wrinkles and elasticity are separate parameters that require their own evaluation methods.
In a randomized, 12-week split-face study involving 50 women, the formulation containing niacinamide was compared with its counterpart and changes in several appearance parameters, including fine lines, pigmentation-related features, and elasticity, were described.[7]
By using a comparison with the background, the study provides useful data regarding the evaluated formulation of niacinamide in the studied population.
However, this was not an investigation of adding peptides to niacinamide.
Therefore, on the basis of this study, it cannot be determined whether adding the peptide would have increased, decreased, or left unchanged any of the observed effects.
Results regarding elasticity should be interpreted with equal caution. Measurement devices can assess certain aspects of the mechanical response of the skin, but improvements in this parameter should not automatically be presented as a measured increase in collagen mass or a lasting structural remodeling.
Such biological claims are stronger and require a different type of evidence.
Different measurement methods can give different results
Different evaluation methods do not always lead to identical conclusions.
In two proof-of-concept studies involving a lamellar cream containing niacinamide, a combination of instrumental, clinical, and photographic assessments were used. Some parameters improved compared to the absence of the product, while an independent photographic assessment did not show a reported improvement in skin texture. [8]
Such a discrepancy is information, not a disadvantage.
It shows that a statistically measurable instrumental change does not necessarily mean an equally obvious change visible to the naked eye.
Instrumental measurements can detect small physical differences that are difficult to notice visually. In contrast, photographic assessment can take into account appearance characteristics that a single instrument does not fully describe.
A balanced interpretation should therefore indicate both the methods that showed a difference and those that did not.
Tolerance of formulations
Tolerance applies to the entire product
Consumers use ready-made formulations, not the names of the ingredients themselves.
Therefore, tolerance depends on the entire product.
The base, concentrations of active ingredients, preservatives, fragrance substances, solvents, the application site, the existing skin condition, and other products used simultaneously can all influence the onset of discomfort.
The fact that niacinamide and selected peptides were well tolerated in certain clinical studies does not mean that every product containing both types of ingredients will be non-irritating.
Another mixture of peptides, a different concentration, or a different vehicle may not be represented by existing studies.
Claims regarding tolerance are also more informative if the study clearly indicates what is being assessed. These may include burning, tingling, dryness, itching, redness, or other reactions along with their severity, duration, and information about participants’ withdrawal.
The statement „no serious adverse reactions were reported” therefore does not mean the same thing as „no participant experienced discomfort”.
The concentration is only one of the variables
Higher concentration of the ingredient does not automatically mean greater effectiveness of the cosmetic product.
Without a controlled comparison of formulations that are similar in composition, the concentration alone does not allow determining whether the product provides a better balance between efficacy and tolerability.
In the case of peptides, an additional complication arises because the percentage given for the „peptidic complex” may refer to the amount of the entire mixture delivered, rather than to the pure peptide itself.
For example, a peptide complex may contain a peptide along with water, solvents, stabilizers, and other substances. A direct comparison of its percentage content with the percentage of niacinamide can therefore mean aggregating incomparable values.
The numbers displayed in product names do not solve this problem.
The product advertised with a certain percentage of niacinamide still requires data regarding the specific formulation and the intended method of use.
The combined product and the set of several products require separate evaluation
One bottle containing niacinamide and peptides is not the same as a skincare set in which these ingredients are contained in different products.
The finished serum that combines the ingredients has a specific formulation environment.
A routine involving several cosmetics exposes the skin to separate bases, concentrations, and subsequent application steps. Changing the order of application can also affect their mutual interaction on the skin surface.
Similarly, the physical mixing of two ready-made cosmetics changes their proportions and the immediate formulation environment.
Data regarding the original products do not automatically characterize the newly created mixture.
The studies discussed in this article do not establish a single universal sequence of administration, waiting time, or frequency of use appropriate for all combinations of nicotinamide with peptides.
Such recommendations should be based on information regarding the specific formulation, and not solely on the names of the categories of ingredients.
The same principle applies to other popular cosmetic ingredients. For vitamin C, the exact chemical form of the ingredient, pH, stability, and complete formulation can all be important factors. This topic is discussed in more detail in the article. Peptides and vitamin C.
The selected volunteers do not represent all skin types.
Clinical studies of cosmetics often involve healthy volunteers selected according to specific inclusion and exclusion criteria.
Participants such as these may differ significantly from people with active eczema, rosacea, allergies, severely damaged skin barrier, or other dermatological problems.
Therefore, the reduction of cosmetically assessed redness in healthy participants cannot be converted into evidence of treatment of rosacea.
Similarly, good tolerance in healthy volunteers does not guarantee identical tolerance in people with a highly reactive skin or with impaired barrier function.
More about the restrictions on transferring general cosmetic data to reactive or acne-prone skin is discussed in the article Peptides for sensitive and acne-prone skin.
Persistent irritation requires appropriate evaluation, especially when several new cosmetics were introduced at about the same time.
The assumption that a product must act soothing only because it contains peptides or niacinamide can make it difficult to recognize that another ingredient or the entire formulation is responsible for the reaction.
Positive tolerance results remain valuable, but their range must be clearly defined. Small and short-term studies are particularly limited in assessing rare or delayed reactions.
What cannot be determined based on the data regarding the ingredients themselves?
The mechanism does not prove the delivery of the component or the visible effect
Cell-based studies are useful for identifying potential biological responses under controlled exposure conditions.
However, they do not reproduce all the stages that occur between applying the cosmetic product to the skin and the appearance of a visible change in the human body.
The peptide must maintain adequate stability in the formulation, be present at the appropriate concentration, and reach the biologically relevant environment before the mechanism observed in the laboratory experiment can become relevant for local application.
Niacinamide is also subject to formulation and delivery-related constraints.
An experiment demonstrating changes in lipid synthesis associated with niacinamide therefore does not prove that adding a peptide to the same bottle intensifies this effect.
Similarly, the evidence that one formulation containing a peptide improved wrinkle parameters does not mean that every multipeptide serum improves skin barrier function.
The data regarding individual components remain valuable because they help formulate hypotheses and select appropriate endpoints.
However, if the claim concerns the actual action of the finished cosmetic product, data relating to the finished formulation are required.
A well-known marketing term does not transfer evidence between products.
Terms such as „peptide booster”, „serum with niacinamide and peptides”, „multipeptide complex” or „barrier-supporting complex” do not constitute standardized scientific definitions.
Two products using almost identical marketing language can contain completely different peptides, their concentrations, bases and excipients.
The mere presence of the brand name in the query searched by the user also does not mean that the given commercial product was evaluated in the cited scientific publication.
The linking of the publication to a product available on the market requires proof that the formulation or intervention under investigation actually corresponds to that product.
An additional problem are the rephrasinges.
The product currently available does not necessarily have the same composition as the version tested a few years ago. Changes in ingredients, concentrations, preservatives, or delivery systems can limit the direct applicability of older studies to the current version.
If the conformity of the formulation under investigation with the current product cannot be confirmed, this uncertainty should be clearly indicated.
The best evidence corresponds exactly to the claim we want to evaluate.
Different claims require different evidence.
If the claim concerns humidity, the test should include an appropriate measurement of humidity.
If it is claimed that the addition of a specific peptide improves the effectiveness of a niacinamide serum, a comparison is needed to distinguish the contribution of this peptide.
If the claim concerns the skin barrier function, the relevant parameters related to the barrier, such as TEWL or other appropriate measurements, should be analyzed.
If a lasting change is being discussed, the observation period should be long enough to assess its persistence, and measurements may be necessary after the product has been discontinued, if appropriate.
This does not mean that every cosmetic study must analyze all possible parameters.
However, it means that the proposal should not be broader than the experiment that is intended to confirm it.
In the case of peptides and niacinamide, existing studies support specific ingredients and specific formulations combined under defined conditions.
However, they do not prove that the combination of the words „peptides” and „niacynamide” alone guarantees the creation of a better serum.
Frequently asked questions
Can a serum contain both peptides and niacinamide at the same time?
Yes. In a published study involving humans, serum containing niacinamide along with postbiotics and peptide components was evaluated.[4] This is direct evidence that these categories of ingredients can coexist in the formulated product under study. However, this does not mean that each serum containing niacinamide and peptides has the same composition, stability, tolerance, or efficacy. Conclusions should remain specific to the particular formulation, comparator product, and evaluated parameters.
Does combining several ingredients guarantee a better result?
No. Placing several components that have been tested separately in a single formulation does not guarantee that the finished product will perform better than any of the individual components. A complete care regimen can produce beneficial results without being able to determine which component is responsible. The study of a regimen containing niacinamide, peptides, and retinyl propionate illustrates this limitation well, because several elements of the intervention differed at the same time. [5] Demonstrating additional benefit requires a comparison that allows the appropriate component to be identified, while proving synergy requires an even more specific study design.
Is niacinamide a peptide?
No. Niacinamide, or nicotinamide, is a form of vitamin B3 and is chemically different from peptides, which consist of amino acid residues linked by peptide bonds. The studies on niacinamide regarding the biology of epidermal lipids therefore refer to a different molecule and other mechanisms than those of cosmetic peptides.[1] The fact that both components can be found in the same cosmetic product does not make them chemically equivalent and does not automatically allow data to be transferred from one component to the other.
Can all cosmetic peptides be treated the same way?
No. Cosmetic peptides can differ in amino acid sequence, molecular size, chemical modifications, the attachment of lipid fragments, stability, and formulation. Controlled testing of a palmitoylated pentapeptide provides data on a specific formulation containing this peptide, not all peptide cosmetics. [2] A common ingredient category does not mean identical delivery, mechanism, or clinical effect.
Does increasing hydration indicate a repair of the skin barrier?
No. Moisture measurements and measurements of skin barrier permeability functions relate to related but different properties. The product may increase the water content in the outer layers of the skin without showing a full restoration or strengthening of the barrier. In studies of nicotinamide, TEWL was analyzed together with additional parameters of the stratum corneum, which shows that the assessment of the barrier may go beyond mere hydration alone. [6] Therefore, improvement in corneometry results should be described as an improvement in hydration rather than automatically as a complete „barrier repair”.
Does the smaller redness mean that the serum treats rosacea?
No. Reducing cosmetically assessed redness does not allow the cause of this redness to be determined and is not in itself evidence of rosacea treatment. A small study of a formulation containing niacinamide, postbiotics, and peptides included healthy participants and selected skin parameters. [4] Conclusions should remain limited to this population and experimental conditions. A claim regarding the treatment of rosacea or another dermatological disease would require appropriately designed clinical studies in people with the disease in question.
Do the wrinkle results prove that the peptides were responsible for the change?
Such assignment is justified only when the design of the study allows for it. A preparation containing a peptide compared to a possibly identical preparation without this peptide provides significantly more information than a multivitamin rutine, where many elements change simultaneously. The study of the palmitoylated pentapeptide used a properly selected comparative preparation and therefore provides useful data regarding the contribution of a specific peptide. [2] Even then the result remains valid for the peptide under study, the formulation, the population and the endpoints.
Is the cell study sufficient to confirm the effectiveness of the finished serum?
No. Cell studies can provide mechanistic information under controlled conditions, but they do not replicate the entire process involving application to the skin, component stability, penetration, metabolism, and the apparent response in humans. Nicotinamide studies regarding lipid synthesis provide valuable biological context, but they cannot independently confirm the action of the unrelated commercial niacinamide and peptide serum. [1]
Does a higher concentration of niacinamide have to work better?
No. A higher percentage value does not in itself indicate greater effectiveness or better tolerance. A clinical study of a specific concentration versus a baseline allows conclusions to be drawn about that particular intervention, rather than creating a universal ranking of niacinamide concentrations. [7] Formulation, delivery method, additional ingredients, and participant characteristics can all influence the results. Determining that one concentration works better than another requires a direct comparison under appropriately similar conditions.
Does a higher number of peptides mean better support for the skin barrier?
No. Neither the total percentage of peptides nor their number in the formula constitute a universal measure of efficacy on the skin barrier. The cited study of palmitoyl pentapeptide concerned fine lines and wrinkles, not the overall effect on the barrier. [2] Products advertised as containing several peptides still need appropriate barrier measurements if such an effect is being claimed.
Is a set of several cosmetics equivalent to a serum containing all the ingredients?
No. A combination of several products creates a different exposure pattern than a single formulation containing all the ingredients together. Each product has its own base, concentrations, and application conditions. Studies of entire care regimens evaluate the complete intervention rather than all possible substitutions or order of application of products.[5] Therefore, their results should not be automatically extrapolated to another set simply because some of the identified ingredients are repeated.
Can objective instrumental measurements replace a control group?
No. Instrumental measurements can increase precision and limit some forms of subjective assessment, but they do not eliminate alternative explanations for the observed change. In studies of lamellar cream, various methods and comparator products were used, and some instrumental and photographic results were inconsistent. [8] This shows that measurement precision and the ability to attribute an effect to a specific cause are separate issues.
Does the effect on skin color indicate an effect on the skin barrier?
No. Pigmentation and the function of the skin barrier involve different biological processes and require separate endpoints. Nicotinamide studies on melanin transfer analyzed mechanisms related to pigmentation and skin appearance, but not all possible aspects of barrier function. [3] Therefore, a positive result regarding color should not be extrapolated to unrelated claims regarding TEWL, hydration, or barrier repair.
Does good tolerance mean that the product will be suitable for everyone?
No. Tolerance data describe specific participants, formulation, method of administration, and the duration of observation of a given study. A cosmetic regimen may be better tolerated than a comparator product, while not being suitable for every person and every skin condition. A randomized study of a skincare regimen provides a relative comparison of tolerance under specific experimental conditions.[5] However, it does not establish universal tolerance, especially in individuals with active dermatological diseases or who are concurrently using other potentially irritating formulations.
Does the term „clinically evaluated” mean independent confirmation of the results?
No. The term „clinically tested” can refer to even a single study and does not inform whether the result was independently replicated. When assessing the strength of the evidence, it is necessary to examine the study design, the sample size, the comparator product, the duration, funding, and whether the result has been replicated by another research group. Proof-of-concept studies can provide valuable preliminary data while leaving important questions regarding replication unanswered. [8]
What could indicate that the combination of peptides with niacinamide works better than niacinamide itself?
It would be useful to conduct a study comparing formulations that are as similar as possible, one of which contains niacinamide and the other the same base with niacinamide and a precisely defined peptide. Subsequently, the previously defined endpoints and tolerability should be evaluated under the same conditions. Additional groups receiving the peptide alone or a combination of both could provide even better information about possible interactions or synergies. A study that simultaneously changes the entire care regimen does not allow this issue to be isolated, because there are too many variables. [5] The most important principle therefore is: the comparator product must correspond to the claim we want to test.
Summary
Peptides and niacinamide can coexist in the cosmetic formulations tested, and published studies involving humans include products and care regimens containing both categories of ingredients. However, the co-occurrence should not be automatically interpreted as evidence of additional benefit, and additional benefit should not automatically be defined as synergy.
Niacinamide and peptides are chemically distinct components with distinct evidence bases. Niacinamide has been studied regarding epidermal lipids, pigmentation, and various skin appearance parameters, whereas individual cosmetic peptides have their own studies depending on their sequence and formulation. The word „peptide” itself does not mean a single standardized cosmetic ingredient; data regarding a single peptide should not be generalized to others.
The formulation itself is equally important. Ready-made serums contain a base, humectants, emollients, preservatives, and potentially many other active ingredients that can affect the measured results. Therefore, the improvement observed after using a multi-ingredient product primarily relates to the complete formulation being tested, unless the experimental design allows the specific component to be identified.
The type of comparator product determines how far conclusions can go. A comparison of a product without use can show an effect related to the use of the entire formulation. A comparison with a properly selected vehicle can provide stronger data regarding the added active ingredient. Proving that a specific peptide improves the efficacy of a formulation containing niacinamide requires proper comparison of the components, and demonstrating synergy requires a design that allows the interaction between them to be investigated.
The endpoints must also remain separated. Hydration is not automatically evidence of repairing the skin barrier. TEWL does not measure collagen production. A reduction in redness does not prove treatment of rosacea. The pigment score does not confirm improvement in barrier function, and the measurement of elasticity should not be automatically interpreted as permanent collagen repair.
Available studies on combined formulations therefore support the cautious conclusion: specific preparations containing niacinamide and peptides may cause measurable changes in skin parameters under certain experimental conditions, but the results remain dependent on the exact formulation, the tested population, the comparator product used, and the measured endpoint.
The most reasonable conclusion therefore is not that adding peptides to niacinamide automatically creates a better serum. Specific combinations can be scientifically tested, and claims regarding their effects should remain proportionate to what experiments have actually shown.
Disclaimer
This article is for educational and scientific information purposes only. It explains issues related to cosmetic ingredients, formulations, and the interpretation of published studies involving niacinamide and skincare products containing peptides. It does not constitute an individual skincare plan, medical advice, diagnosis, therapeutic recommendation, or instructions for use of a specific cosmetic product.
Discussion of niacinamide, peptides, hydration, intertriginous water loss, redness, pigmentation, wrinkles, elasticity, and tolerance should not be interpreted as evidence that a specific commercial product will provide the same results as the preparations described in the cited studies. Products using similar names of ingredients may significantly differ in peptide identity, concentration, formulation base, additional ingredients, and use conditions.
Similarly, cosmetic results regarding redness, pigmentation, or skin barrier-related parameters should not be interpreted as evidence that the formulation diagnoses, prevents, or treats rosacea, eczema, or other dermatological disease. Claims regarding diseases require studies specifically designed for the specific condition and the appropriate population.
Individual skin reactions can vary, especially when several new products are introduced at the same time or when the skin is already irritated or has a dermatological condition. Persistent or significant irritation and questions about existing skin problems should be evaluated by a suitably qualified physician or dermatologist, and not based on general information about cosmetic ingredients.
References
- Tanno, O., Ota, Y., Kitamura, N., Katsube, T., & Inoue, S. (2000). Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. British Journal of Dermatology, 143(3), 524–531. https://doi.org/10.1111/j.1365-2133.2000.03705.x
- Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x
- Hakozaki, T., Minwalla, L., Zhuang, J., Chhoa, M., Matsubara, A., Miyamoto, K., Greatens, A., Hillebrand, G. G., Bissett, D. L., & Boissy, R. E. (2002). The effect of niacinamide on reducing cutaneous pigmentation and suppressing melanosome transfer. British Journal of Dermatology, 147(1), 20–31. https://doi.org/10.1046/j.1365-2133.2002.04834.x
- Rusic, D., Ivic, M., Slugan, A., Leskur, D., Modun, D., Durdov, T., Vukovic, D., Bukic, J., Bozic, J., & Seselja Perisin, A. (2024). Pilot study on the effects of a cosmetic serum containing niacinamide, postbiotics, and peptides on facial skin in healthy participants: A randomized controlled trial. Life, 14(12), Article 1677. https://doi.org/10.3390/life14121677
- Fu, J. J., Hillebrand, G. G., Raleigh, P., Li, J., Marmor, M. J., Bertucci, V., Grimes, P. E., Mandy, S. H., Perez, M. I., Weinkle, S. H., & Kaczvinsky, J. R. (2010). A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen. British Journal of Dermatology, 162(3), 647–654. https://doi.org/10.1111/j.1365-2133.2009.09436.x
- Mohammed, D., Crowther, J. M., Matts, P. J., Hadgraft, J., & Lane, M. E. (2013). Influence of niacinamide-containing formulations on the molecular and biophysical properties of the stratum corneum. International Journal of Pharmaceutics, 441(1-2), 192–201. https://doi.org/10.1016/j.ijpharm.2012.11.043
- Bissett, D. L., Oblong, J. E., & Berge, C. A. (2005). Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatological Surgery, 31(7 Pt 2), 860–865. https://doi.org/10.1111/j.1524-4725.2005.31732
- Nisbet, S., Mahalingam, H., Gfeller, C. F., Biggs, E., Lucas, S., Thompson, M., Cargill, M. R., Moore, D., & Bielfeldt, S. (2019). Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies. International Journal of Cosmetic Science, 41(1), 1–11. https://doi.org/10.1111/ics.12499